RNP antibodies target a complex containing a series of snRNP including three polypeptides (68 kD, A and C) that are linked non-covalently with U1-RNA as part of the spliceosome complex.
These autoantibodies have a specificity of 100 % for Sharp Syndrome.
Recombinant, human, expressed in Baculovirus-infected Sf9 cells (for more information on our antigens click here)